Futura Medical plc. 

(Public, LON:FUM)   Watch this stock   
Find more results forFUM
Sep 23, 2009
Interim 2009 FUTURA MED PLC Earnings Release
Sep 23, 2009
Interim 2009 FUTURA MED PLC Earnings Presentation
  

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin - -1290.67%
Operating margin - -1450.67%
EBITD margin - -1440.00%
Return on average assets -112.82% -93.78%
Return on average equity -128.42% -105.82%
Employees 3 -

Address

Surrey Technology Centre 40 Occam Road The Surrey Research Park
Guildford, ENG GU2 7YG
United Kingdom - Map
+44-1483-685670 (Phone)
+44-1483-685671 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Futura Medical plc. discussions

  View all discussions »

Description

Futura Medical plc (Futura) is a United Kingdom-based company engaged research and development of pharmaceutical drugs and medical devices and its commercial exploitation. The Company is focuses on developing a portfolio of products in sexual healthcare and pain relief management. Its products include CSD500, MED2002, TPR100, PET500 and RAD100. CSD500 is a condom that incorporates an erectogenic compound, which comes into contact with the penis on application of the condom. MED2002 is a rub-on gel applied directly to the penis for the treatment of male erectile dysfunction. TPR100 is a product for the provision of topical pain relief. PET500 is an over the counter treatment for premature ejaculation using anaesthetic compounds. RAD100 is product, which provides rapid local anaesthesia prior to injections.

Officers and directors

William Duncan Potter Ph.D.
Executive Chairman of the Board
James Henry Barder
Chief Executive Officer, Executive Director
Age: 48
Derek Adrian Martin
Finance Director, Company Secretary, Executive Director
David B. Davies
Product Development Director, Executive Director
Portrait
Jonathan David Freeman
Senior Independent Non-Executive Director
Age: 43
Lisa Arnold
Independent Non-Executive Director